Back

Epigenetic BET protein signaling drives autophagy dysfunction in HFpEF

11 May 2026 (13:57 - 14:11)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award (YIA) Basic Science Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ludovica Di Venanzio

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)

3 More presentations in this session

Presentation thumbnail
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy
Mr F. Deiman (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Prognostic value of right ventricular systolic function markers in ATTR-CM
Mr A. Moniz Garcia (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
VasCraft: a human decellularized and re-endothelialized tissue-engineered vascular graft for coronary arterial revascularization
Miss G. Iraola Picornell (Badalona, Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award (YIA) Basic Science
Video

The Event

Event poster

Heart Failure 2026

11 May 2026 13:57 CET
You may be interested in
thumbnail
Congress Presentation
Chromatin-editing drugs in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Epigenetic editing of BET proteins restores autophagy and cardiac function in cardiometabolic heart failure with preserved ejection fraction
thumbnail
Congress Presentation
The epi-drug RVX-208 restores autophagy in cardiometabolic heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources